Newsroom

Alzheimer's Matters Blog

Developing Drugs

Top Five Highlights from AAIC 2018

The ADDF looks back at the 2018 Alzheimer's Association International Conference.

Wolf Blitzer and Dr. Ron Crystal

Developing Drugs

Gene Therapy, A New Frontier in Alzheimer’s

Dr. Ron Crystal and his team at Weill Cornell developed a gene therapy to replace APOE4 with APOE2, which would significantly lower Alzheimer's risk.

Marlee Berliner and Rachel Williams

Understanding Dementia

Familial Alzheimer’s Disease, Explained

Learn about early-onset familial Alzheimer's disease, which can strike people as early as their 30s or 40s.

Resources

Featured Video

Developed by Dr. Roberta Diaz Brinton, allopregnanolone could become the first regenerative therapy for Alzheimer's. Support from the ADDF helped Dr. Brinton turn her idea into a therapy that is now in phase 2 clinical trials.

View more on our YouTube channel

Fact Sheets & Publications